nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Building a CAT clinic - real-world systems approaches to prevention and treatment
|
Angelini, Dana E. |
|
|
213 |
S1 |
p. S84-S86 |
artikel |
2 |
Cancer-associated non-bacterial thrombotic endocarditis
|
Itzhaki Ben Zadok, Osnat |
|
|
213 |
S1 |
p. S127-S132 |
artikel |
3 |
Cancer genetic alterations and risk of venous thromboembolism
|
Mantha, Simon |
|
|
213 |
S1 |
p. S29-S34 |
artikel |
4 |
Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms
|
Pantazi, Despoina |
|
|
213 |
S1 |
p. S95-S102 |
artikel |
5 |
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors
|
Fuster, José J. |
|
|
213 |
S1 |
p. S107-S112 |
artikel |
6 |
Contemporary breast cancer treatment-associated thrombosis
|
Kirwan, Cliona C. |
|
|
213 |
S1 |
p. S8-S15 |
artikel |
7 |
Contents Page
|
|
|
|
213 |
S1 |
p. iv-v |
artikel |
8 |
COVID-19 associated coagulopathy and thrombosis in cancer
|
Levi, Marcel |
|
|
213 |
S1 |
p. S72-S76 |
artikel |
9 |
Crosstalk between hemostasis and immunity in cancer pathogenesis
|
Palumbo, Joseph S. |
|
|
213 |
S1 |
p. S3-S7 |
artikel |
10 |
Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer
|
Wang, Tzu-Fei |
|
|
213 |
S1 |
p. S66-S71 |
artikel |
11 |
Editorial Board
|
|
|
|
213 |
S1 |
p. IFC |
artikel |
12 |
Evolving data on cardiovascular complications in cancer
|
Willems, Ruth A.L. |
|
|
213 |
S1 |
p. S87-S94 |
artikel |
13 |
18F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?
|
Delluc, Aurélien |
|
|
213 |
S1 |
p. S42-S45 |
artikel |
14 |
Hemostatic system activation in breast cancer: Searching for new biomarkers for cancer risk prediction and outcomes
|
Marchetti, Marina |
|
|
213 |
S1 |
p. S46-S50 |
artikel |
15 |
Neutrophil extracellular traps and cancer-associated thrombosis
|
Rosell, Axel |
|
|
213 |
S1 |
p. S35-S41 |
artikel |
16 |
Old is new again: Emergence of thromboembolic complications in cancer patients on immunotherapy
|
McCrae, Keith R. |
|
|
213 |
S1 |
p. S51-S57 |
artikel |
17 |
Optimizing antithrombotic therapy for atrial fibrillation in cancer
|
Tufano, Antonella |
|
|
213 |
S1 |
p. S103-S106 |
artikel |
18 |
Preface to the Proceedings of the 11th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2022
|
Falanga, Anna |
|
|
213 |
S1 |
p. S1-S2 |
artikel |
19 |
The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer
|
Sarantis, Panagiotis |
|
|
213 |
S1 |
p. S120-S126 |
artikel |
20 |
The impact of warfarin on overall survival in cancer patients
|
Chiasakul, Thita |
|
|
213 |
S1 |
p. S113-S119 |
artikel |
21 |
The role of P-selectin in cancer-associated thrombosis and beyond
|
Yeini, Eilam |
|
|
213 |
S1 |
p. S22-S28 |
artikel |
22 |
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer
|
Connors, Jean M. |
|
|
213 |
S1 |
p. S77-S83 |
artikel |
23 |
Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
|
Moik, Florian |
|
|
213 |
S1 |
p. S58-S65 |
artikel |
24 |
Venous thromboembolism and risk stratification in hematological malignancies
|
Sanfilippo, Kristen M. |
|
|
213 |
S1 |
p. S16-S21 |
artikel |